2 active not recruiting, 2 recruiting, 1 completed, 1 terminated. 3 Phase 2, 2 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Active not recruiting 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Not applicable | 1 | Active not recruiting 1 |
Follow Recurrent Malignant Female Reproductive System Neoplasm: new trials by email Literature Review of Recurrent Malignant Female Reproductive System Neoplasm trials Research Report on Recurrent Malignant Female Reproductive System Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial) Biopsy Procedure, Biospecimen Collection, Computed Tomography - Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm | Phase 2 | Recruiting | National Cancer Institute (NCI) | 70 | 2024-05-07 | 2026-10-19 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial Alpelisib, Binimetinib, Biopsy Procedure - Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8 | Phase 2 | Recruiting | National Cancer Institute (NCI) | 2900 | 2023-04-07 | 2026-10-15 |
| Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies Durvalumab, Internal Radiation Therapy, Tremelimumab - Metastatic Malignant Female Reproductive System Neoplasm, Platinum-Resistant Malignant Female Reproductive System Neoplasm | Phase 2 | Active not recruiting | Jonsson Comprehensive Cancer Center | 9 | 2020-08-07 | 2026-07-17 |
| Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis Ipilimumab, Laboratory Biomarker Analysis, Nivolumab - Malignant Peritoneal Neoplasm, Malignant Retroperitoneal Neoplasm | Phase 1 | Completed | M.D. Anderson Cancer Center | 26 | 2018-09-21 | 2025-05-22 |
| Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer Best Practice, Hypnotherapy, Quality-of-Life Assessment - Malignant Female Reproductive System Neoplasm, Recurrent Malignant Female Reproductive System Neoplasm | Not applicable | Active not recruiting | M.D. Anderson Cancer Center | 152 | 2018-09-11 | 2026-09-18 |
| Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors Cord Blood-derived Expanded Allogeneic Natural Killer Cells, Cyclophosphamide, Etoposide - Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma | Phase 1 | Terminated | M.D. Anderson Cancer Center | 12 | 2018-08-31 | 2026-03-20 |
Endometrial Neoplasms (2) · Fallopian Tube Neoplasms (2) · Ovarian Neoplasms (2) · Uterine Cervical Neoplasms (2) · Bone Neoplasms (1) · Endocrine Gland Neoplasms (1) · Melanoma (1) · Mesothelioma, Malignant (1) · Mouth Neoplasms (1) · Neoplasm Metastasis (1) · Peritoneal Neoplasms (1) · Pharyngeal Neoplasms (1) · Sarcoma (1) · Skin Neoplasms (1) · Thyroid Neoplasms (1)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Neoplasms (4) · Neoplasms by Site (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4) · Endocrine System Diseases (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Uterine Diseases (3) · Uterine Neoplasms (3) · Adnexal Diseases (2) · Endocrine Gland Neoplasms (2) · Fallopian Tube Diseases (2)
Biopsy (2) · Magnetic Resonance Spectroscopy (2) · Specimen Handling (2) · neratinib (2) · palbociclib (2) · Alpelisib (1) · Brachytherapy (1) · CTLA-4 Antigen (1) · Cyclophosphamide (1) · Disulfides (1) · Etoposide (1) · Fluorouracil (1) · Fulvestrant (1) · Hypnosis (1) · Immunoglobulin G (1)
M.D. Anderson Cancer Center (3) · National Cancer Institute (NCI) (2) · Jonsson Comprehensive Cancer Center (1)
United States (6) · Puerto Rico (2)
Albert J Chang (1) · Amir A Jazaeri (1) · Demetrios Petropoulos (1) · Haider S Mahdi (1) · James M Ford (1) · Larissa A Meyer (1)
P30CA016672 (1), U10CA180820 (1), U10CA180868 (1)